Forimtamig is a bispecific antibody being studied for use in myeloma that binds to both CD3 on T cells and GPRC5D expressed on certain tumor cells.
| SparkCures ID | 728 |
|---|---|
| Generic Name | Forimtamig |
There are no resources, links or videos to display for this treatment.